Page last updated: 2024-10-17

creatine and Movement Disorders

creatine has been researched along with Movement Disorders in 50 studies

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research Excerpts

ExcerptRelevanceReference
"Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD."7.96Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020)
"Cerebral creatine deficiency syndromes (CCDS) are a group of inborn errors of creatine metabolism that involve AGAT and GAMT for creatine biosynthesis disorders and SLC6A8 for creatine transporter (CT1) deficiency."7.79Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes. ( Comeaux, MS; Craigen, WJ; Kleppe, S; Renaud, D; Schmitt, ES; Sun, Q; Wang, G; Wang, J; Wong, LJ; Zhang, VW, 2013)
"Epilepsy is one of the main symptoms in GAMT and CT1 deficiency, whereas the occurrence of febrile convulsions in infancy is a relatively common presenting symptom in all the three above-mentioned diseases."6.49Inborn errors of creatine metabolism and epilepsy. ( Battini, R; Cioni, G; Leuzzi, V; Mastrangelo, M, 2013)
"Although epilepsy was not affected by orally administered creatine (400 to 500 mg/kg per day), this treatment resulted in clinical improvement and an increase of creatine in cerebrospinal fluid and brain tissue."5.30Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. ( Bachert, P; Bremer, HJ; De Deyn, PP; Hess, T; Knopp, MV; Marescau, B; Mayatepek, E; Rating, D; Schulze, A; Wevers, R, 1997)
"Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD."3.96Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020)
" Brain creatine depletion and guanidinoacetate accumulation cause developmental delay, seizures and movement disorder."3.88Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study. ( Abdenur, J; Anastasi, A; Ballhausen, D; Billette de Villemeur, T; Buoni, S; Chan, A; Cheillan, D; Dorison, N; Goldenberg, A; Goldstein, J; Hofstede, FC; Jacquemont, ML; Khaikin, Y; Koeberl, DD; Lion-Francois, L; Lund, AM; Mention, K; Mercimek-Andrews, S; Mundy, H; O'Rourke, D; Pitelet, G; Raspall-Chaure, M; Salomons, GS; Sidky, S; Tassini, M; Williams, M, 2018)
"Cerebral creatine deficiency syndromes are neurometabolic conditions characterized by intellectual disability, seizures, speech delay, and behavioral abnormalities."3.85Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics. ( Bodamer, O; Longo, N; Sharer, JD; Tortorelli, S; Wamelink, MM; Young, S, 2017)
"Cerebral creatine deficiency syndromes (CCDS) are a group of inborn errors of creatine metabolism that involve AGAT and GAMT for creatine biosynthesis disorders and SLC6A8 for creatine transporter (CT1) deficiency."3.79Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes. ( Comeaux, MS; Craigen, WJ; Kleppe, S; Renaud, D; Schmitt, ES; Sun, Q; Wang, G; Wang, J; Wong, LJ; Zhang, VW, 2013)
"Epilepsy is one of the main symptoms in GAMT and CT1 deficiency, whereas the occurrence of febrile convulsions in infancy is a relatively common presenting symptom in all the three above-mentioned diseases."2.49Inborn errors of creatine metabolism and epilepsy. ( Battini, R; Cioni, G; Leuzzi, V; Mastrangelo, M, 2013)
"Lack of CRE in the brain can cause intellectual disability, autistic-like behavior, seizures, and movement disorders."1.72Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency. ( Borden, K; Caggana, M; Morrissey, M; Showers, A; Sicko, R; Sunny, S; Teta, B; Wojcik, M, 2022)
"Treatment with creatine (250-1000 mg/kg/day), ornithine (100-800 mg/kg/day), and sodium benzoate (50-135 mg/kg/day) supplements along with dietary protein restriction (0."1.39Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency. ( Botto, LD; Ernst, SL; Hedlund, G; Longo, N; Pasquali, M; Viau, KS, 2013)
"Severe expressive language delay is a constant feature even in the mildest clinical phenotypes."1.35Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language. ( Jakobs, C; King, MD; Monavari, A; O'Rourke, DJ; Ryan, S; Salomons, G, 2009)
"Although epilepsy was not affected by orally administered creatine (400 to 500 mg/kg per day), this treatment resulted in clinical improvement and an increase of creatine in cerebrospinal fluid and brain tissue."1.30Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. ( Bachert, P; Bremer, HJ; De Deyn, PP; Hess, T; Knopp, MV; Marescau, B; Mayatepek, E; Rating, D; Schulze, A; Wevers, R, 1997)

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (10.00)18.2507
2000's5 (10.00)29.6817
2010's31 (62.00)24.3611
2020's9 (18.00)2.80

Authors

AuthorsStudies
Passi, GR1
Pandey, S1
Devi, ARR1
Konanki, R1
Jain, AR1
Bhatnagar, S1
Tripathi, R1
Jain, V1
Wojcik, M1
Morrissey, M1
Borden, K1
Teta, B1
Sicko, R1
Showers, A1
Sunny, S1
Caggana, M1
Ream, MA1
Lam, WKK1
Grosse, SD1
Ojodu, J1
Jones, E1
Prosser, LA1
Rose, AM1
Comeau, AM1
Tanksley, S1
Powell, CM1
Kemper, AR1
Balestrino, M2
Adriano, E2
Sun, W2
Wu, B2
Wu, M1
Yang, B1
Zhang, P2
Xiao, F1
Shi, Y1
Wu, H1
Zhou, W1
Bahl, S1
Cordeiro, D1
MacNeil, L1
Schulze, A6
Mercimek-Andrews, S2
Branovets, J2
Karro, N1
Barsunova, K1
Laasmaa, M1
Lygate, CA2
Vendelin, M2
Birkedal, R2
Rossi, L1
Nardecchia, F1
Pierigè, F1
Ventura, R1
Carducci, C2
Leuzzi, V5
Magnani, M1
Cabib, S1
Pascucci, T1
Wang, Y1
Zu, Z1
Jiang, Y1
Lu, W1
Wang, H1
Peng, X1
Zhou, H1
Gulino, M1
Arkel, M1
Salis, A1
Damonte, G1
Liessi, N1
Millo, E1
Garbati, P1
Khaikin, Y1
Sidky, S1
Abdenur, J1
Anastasi, A1
Ballhausen, D1
Buoni, S1
Chan, A2
Cheillan, D2
Dorison, N1
Goldenberg, A1
Goldstein, J1
Hofstede, FC1
Jacquemont, ML1
Koeberl, DD2
Lion-Francois, L1
Lund, AM1
Mention, K1
Mundy, H1
O'Rourke, D1
Pitelet, G1
Raspall-Chaure, M1
Tassini, M1
Billette de Villemeur, T1
Williams, M1
Salomons, GS4
Benoit, R1
Samir, M1
Boutin, J1
Samuel, A1
Brigitte, C1
Dominique, D1
Isabelle, RV1
Pearson, TS1
Pons, R1
Ghaoui, R1
Sue, CM1
Demartini, B1
Gambini, O1
Uggetti, C1
Cariati, M1
Cadioli, M1
Goeta, D1
Marceglia, S1
Ferrucci, R1
Priori, A1
Rostami, P1
Hosseinpour, S1
Ashrafi, MR1
Alizadeh, H1
Garshasbi, M1
Tavasoli, AR1
El-Gharbawy, AH1
Goldstein, JL1
Millington, DS1
Vaisnins, AE1
Schlune, A2
Barshop, BA1
Young, SP1
Comeaux, MS1
Wang, J1
Wang, G1
Kleppe, S1
Zhang, VW1
Schmitt, ES1
Craigen, WJ1
Renaud, D2
Sun, Q1
Wong, LJ1
Sepp, M1
Kotlyarova, S1
Jepihhina, N1
Sokolova, N1
Aksentijevic, D1
Neubauer, S1
Viau, KS1
Ernst, SL1
Pasquali, M2
Botto, LD1
Hedlund, G1
Longo, N4
Stockler-Ipsiroglu, S2
van Karnebeek, C1
Korenke, GC1
Mercimek-Mahmutoglu, S4
Marquart, I1
Barshop, B1
Grolik, C2
Angle, B1
Araújo, HC2
Coskun, T1
Diogo, L1
Geraghty, M1
Haliloglu, G1
Konstantopoulou, V1
Levtova, A1
Mackenzie, J1
Maranda, B1
Mhanni, AA1
Mitchell, G1
Morris, A1
Newlove, T1
Scaglia, F1
Valayannopoulos, V1
van Spronsen, FJ1
Verbruggen, KT1
Yuskiv, N1
Nyhan, W1
Braissant, O3
Schwarz, E1
Jensen, M1
Yuzyuk, T1
DeBiase, I1
Randall, H1
Pitt, JJ1
Tzanakos, N1
Nguyen, T1
Ma, Y1
Zhan, M1
OuYang, L1
Li, Y1
Chen, S1
Wu, J1
Chen, J1
Luo, C1
Lei, W1
Tran, C1
Yazdanpanah, M1
Kyriakopoulou, L1
Levandovskiy, V1
Zahid, H1
Naufer, A1
Isbrandt, D1
van Karnebeek, CD1
Iqbal, S1
Ali, M1
Iqbal, F2
Clark, JF1
Cecil, KM1
Joncquel-Chevalier Curt, M1
Voicu, PM1
Fontaine, M1
Dessein, AF1
Porchet, N1
Mention-Mulliez, K1
Dobbelaere, D1
Soto-Ares, G1
Vamecq, J1
Hanna-El-Daher, L1
Pacheva, I1
Ivanov, I1
Penkov, M1
Kancheva, D1
Jordanova, A1
Ivanova, M1
Sharer, JD1
Bodamer, O1
Tortorelli, S1
Wamelink, MM1
Young, S1
Stern, WM1
Winston, JS1
Murphy, E1
Cross, JH1
Sander, JW1
O'Rourke, DJ1
Ryan, S1
Salomons, G1
Jakobs, C3
Monavari, A1
King, MD1
Nasrallah, F1
Feki, M1
Kaabachi, N1
Boenzi, S1
Pastore, A1
Martinelli, D1
Goffredo, BM1
Boiani, A1
Rizzo, C1
Dionisi-Vici, C1
Sinclair, G1
van Dooren, SJ1
Kanhai, W1
Ashcraft, P1
Michel, OJ1
Nelson, J1
Betsalel, OT1
Sweetman, L1
Mastrangelo, M1
Battini, R1
Cioni, G2
Sun, Z1
Yang, X1
Ye, H1
Zhou, G1
Jiang, H1
Stoeckler-Ipsiroglu, S1
Adami, A1
Appleton, R1
Duran, M1
Ensenauer, R1
Fernandez-Alvarez, E1
Garcia, P1
Item, CB1
Marquardt, I1
Mühl, A1
Saelke-Kellermann, RA1
Surtees, R1
van der Knaap, MS1
Vasconcelos, R1
Verhoeven, NM1
Vilarinho, L1
Wilichowski, E1
Henry, H1
Stöckler, S1
Marescau, B2
De Deyn, PP2
Trijbels, JM1
Hanefeld, F2
Hess, T1
Wevers, R1
Mayatepek, E1
Bachert, P1
Knopp, MV1
Bremer, HJ1
Rating, D1
Kim, MO1
Im, JH1
Choi, CG1
Lee, MC1
Taylor-Robinson, SD1
Turjanski, N1
Bhattacharya, S1
Seery, JP1
Sargentoni, J1
Brooks, DJ1
Bryant, DJ1
Cox, IJ1
Pouwels, PJ1
Brockmann, K1
Kruse, B1
Wilken, B1
Wick, M1
Frahm, J1
Shear, DA1
Haik, KL1
Dunbar, GL1
Bianchi, MC1
Tosetti, M1
Cerquiglini, CA1
Antonozzi, I1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms - a Pilot Study Protocol[NCT05562232]45 participants (Anticipated)Interventional2022-10-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

11 reviews available for creatine and Movement Disorders

ArticleYear
Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency.
    Genes, 2021, 08-02, Volume: 12, Issue:8

    Topics: Animals; Brain; Creatine; Disease Models, Animal; Guanidinoacetate N-Methyltransferase; Intellectual

2021
Genetic mimics of cerebral palsy.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:5

    Topics: Adenylyl Cyclases; Ataxia; Ataxia Telangiectasia; Brain; Brain Diseases, Metabolic, Inborn; Carbohyd

2019
Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review.
    Acta neurologica Belgica, 2020, Volume: 120, Issue:3

    Topics: Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Creatine; Delayed Diagnosis; Development

2020
Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Seminars in neurology, 2014, Volume: 34, Issue:3

    Topics: Amidinotransferases; Brain Diseases, Metabolic, Inborn; Creatine; Guanidinoacetate N-Methyltransfera

2014
Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes.
    Pediatric research, 2015, Volume: 77, Issue:3

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic, Inborn; Creati

2015
Creatine biosynthesis and transport in health and disease.
    Biochimie, 2015, Volume: 119

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Amino Acid Transport Systems, Basic; AMP-

2015
Review: Human guanidinoacetate n-methyl transferase (GAMT) deficiency: A treatable inborn error of metabolism.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:6

    Topics: Arginine; Creatine; Dietary Proteins; Dietary Supplements; Energy Metabolism; Genetic Predisposition

2015
Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?
    Amino acids, 2016, Volume: 48, Issue:8

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Blood-Brain Barrier; Brain Disea

2016
Creatine and creatine deficiency syndromes: biochemical and clinical aspects.
    Pediatric neurology, 2010, Volume: 42, Issue:3

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Autistic Disorder; Child; Creatine; Epile

2010
Inborn errors of creatine metabolism and epilepsy.
    Epilepsia, 2013, Volume: 54, Issue:2

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic, Inbor

2013
AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.
    Journal of inherited metabolic disease, 2008, Volume: 31, Issue:2

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Brain; Creatine; Developmental D

2008

Other Studies

39 other studies available for creatine and Movement Disorders

ArticleYear
Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
    Brain & development, 2022, Volume: 44, Issue:4

    Topics: Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Creatine; Female; Follow-Up Studies; Gua

2022
Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency.
    Molecular genetics and metabolism, 2022, Volume: 135, Issue:3

    Topics: Creatine; Guanidinoacetate N-Methyltransferase; Humans; Infant, Newborn; Intellectual Disability; La

2022
Evidence and Recommendation for Guanidinoacetate Methyltransferase Deficiency Newborn Screening.
    Pediatrics, 2023, 08-01, Volume: 152, Issue:2

    Topics: Child; Creatine; Guanidinoacetate N-Methyltransferase; Humans; Infant, Newborn; Language Development

2023
Presence of guanidinoacetate may compensate creatine absence and account for less statin-induced muscle damage in GAMT-deficient compared to AGAT-deficient mice.
    Amino acids, 2020, Volume: 52, Issue:4

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Creatine; Developmental Disabili

2020
[Genetic analysis and treatment for an infant with cerebral creatine deficiency syndrome type 2].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2020, Sep-10, Volume: 37, Issue:9

    Topics: Brain Diseases, Metabolic, Inborn; Creatine; Female; Guanidinoacetate N-Methyltransferase; Humans; I

2020
Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.
    Orphanet journal of rare diseases, 2020, 12-02, Volume: 15, Issue:1

    Topics: Brain Diseases, Metabolic, Inborn; Canada; Creatine; Female; Guanidinoacetate N-Methyltransferase; H

2020
Cardiac expression and location of hexokinase changes in a mouse model of pure creatine deficiency.
    American journal of physiology. Heart and circulatory physiology, 2021, 02-01, Volume: 320, Issue:2

    Topics: Adenosine Diphosphate; Adenylate Kinase; Amidinotransferases; Amino Acid Metabolism, Inborn Errors;

2021
First reported Chinese case of guanidinoacetate methyltransferase deficiency in a 4-year-old child.
    Clinica chimica acta; international journal of clinical chemistry, 2017, Volume: 470

    Topics: Child, Preschool; Creatine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Guanidinoac

2017
Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency.
    Neuroscience letters, 2018, 02-05, Volume: 665

    Topics: Animals; Brain; Brain Diseases, Metabolic, Inborn; Creatine; Guanidinoacetate N-Methyltransferase; L

2018
Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2018, Volume: 22, Issue:3

    Topics: Cohort Studies; Creatine; Diet, Protein-Restricted; Female; Guanidinoacetate N-Methyltransferase; Hu

2018
LC-MS/MS measurements of urinary guanidinoacetic acid and creatine: Method optimization by deleting derivatization step.
    Clinica chimica acta; international journal of clinical chemistry, 2019, Volume: 493

    Topics: Chromatography, High Pressure Liquid; Clinical Laboratory Techniques; Creatine; Glycine; Guanidinoac

2019
Limbic neurochemical changes in patients with functional motor symptoms.
    Neurology, 2019, 07-02, Volume: 93, Issue:1

    Topics: Adult; Affective Symptoms; Anxiety; Case-Control Studies; Creatine; Depression; Female; Glutamic Aci

2019
Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency.
    Molecular genetics and metabolism, 2013, Volume: 109, Issue:2

    Topics: Case-Control Studies; Child, Preschool; Creatine; Dried Blood Spot Testing; Early Diagnosis; Female;

2013
Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.
    Molecular genetics and metabolism, 2013, Volume: 109, Issue:3

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic, Inborn; Creati

2013
Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT-/- mouse hearts.
    American journal of physiology. Heart and circulatory physiology, 2013, Aug-15, Volume: 305, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Creatine; Creatin

2013
Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.
    Molecular genetics and metabolism, 2013, Volume: 110, Issue:3

    Topics: Creatine; Diet, Protein-Restricted; Female; Genotype; Guanidinoacetate N-Methyltransferase; Humans;

2013
Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring.
    Molecular genetics and metabolism, 2014, Volume: 111, Issue:1

    Topics: Adolescent; Adult; Arginine; Brain; Child; Child, Preschool; Combined Modality Therapy; Creatine; Fe

2014
GAMT deficiency: 20 years of a treatable inborn error of metabolism.
    Molecular genetics and metabolism, 2014, Volume: 111, Issue:1

    Topics: Arginine; Creatine; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Intellectual Disa

2014
Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency.
    Journal of inherited metabolic disease, 2014, Volume: 37, Issue:2

    Topics: Brain; Creatine; Dried Blood Spot Testing; False Positive Reactions; Feasibility Studies; Glycine; G

2014
Newborn screening for guanidinoacetate methyl transferase deficiency.
    Molecular genetics and metabolism, 2014, Volume: 111, Issue:3

    Topics: Arginine; Creatine; Diet; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Intellectua

2014
The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.
    Behavioural brain research, 2014, Jun-01, Volume: 266

    Topics: Adrenergic Agents; Animals; Apomorphine; Choline O-Acetyltransferase; Cognition Disorders; Corpus St

2014
Case study for the evaluation of current treatment recommendations of guanidinoacetate methyltransferase deficiency: ineffectiveness of sodium benzoate.
    Pediatric neurology, 2014, Volume: 51, Issue:1

    Topics: Amino Acids; Child; Creatine; Dietary Supplements; Female; Food Preservatives; Guanidinoacetate N-Me

2014
Stable isotope dilution microquantification of creatine metabolites in plasma, whole blood and dried blood spots for pharmacological studies in mouse models of creatine deficiency.
    Clinica chimica acta; international journal of clinical chemistry, 2014, Sep-25, Volume: 436

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Chromatography, Liquid; Creatine

2014
Long term creatine monohydrate supplementation, following neonatal hypoxic ischemic insult, improves neuromuscular coordination and spatial learning in male albino mouse.
    Brain research, 2015, Apr-07, Volume: 1603

    Topics: Animals; Body Weight; Carotid Artery Diseases; Creatine; Disease Models, Animal; Hypoxia-Ischemia, B

2015
Creatine Deficiency Syndrome could be Missed Easily: A Case Report of Guanidinoacetate Methyltransferase Deficiency Presented with Neurodevelopmental Delay, Seizures, and Behavioral Changes, but Normal Structural MRI.
    Annals of clinical and laboratory science, 2016, Volume: 46, Issue:5

    Topics: Child; Child Behavior; Child, Preschool; Creatine; Developmental Disabilities; Guanidinoacetate N-Me

2016
Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.
    Genetics in medicine : official journal of the American College of Medical Genetics, 2017, Volume: 19, Issue:2

    Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic, Inborn; Clinic

2017
Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy.
    Practical neurology, 2017, Volume: 17, Issue:3

    Topics: Adult; Creatine; Epilepsy; Guanidinoacetate N-Methyltransferase; Humans; Language Development Disord

2017
Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language.
    Developmental medicine and child neurology, 2009, Volume: 51, Issue:5

    Topics: Administration, Oral; Adolescent; Age of Onset; Biomarkers; Brain; Creatine; Creatinine; Female; Gua

2009
Creatine metabolism in urea cycle defects.
    Journal of inherited metabolic disease, 2012, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Amidinotransferases; Arginine; Child; Child, Preschool; Creatine; Female; Guanidi

2012
Guanidinoacetate methyltransferase deficiency: first steps to newborn screening for a treatable neurometabolic disease.
    Molecular genetics and metabolism, 2012, Volume: 107, Issue:3

    Topics: Adult; Alleles; Base Sequence; Creatine; DNA Mutational Analysis; Early Diagnosis; Female; Gene Freq

2012
Delayed encephalopathy with movement disorder and catatonia: a rare combination after wasp stings.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:8

    Topics: Adult; Animals; Brain; Catatonia; Creatine; Electrocardiography; Electroencephalography; Globus Pall

2013
GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis.
    Neurology, 2006, Aug-08, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Child; Creatine; Epilepsy; Female; Glycine; Guanidinoacetate N-Methyltransferase;

2006
Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:10

    Topics: Administration, Oral; Amino Acid Metabolism, Inborn Errors; Creatine; Creatinine; Guanidines; Guanid

1997
Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism.
    The Journal of pediatrics, 1997, Volume: 131, Issue:4

    Topics: Amino Acid Metabolism, Inborn Errors; Brain; Cells, Cultured; Child, Preschool; Creatine; Creatinine

1997
Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:3

    Topics: Acetylcholine; Adolescent; Adult; Aged; Basal Ganglia; Brain; Brain Mapping; Choline; Creatine; Domi

1998
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
    Metabolic brain disease, 1999, Volume: 14, Issue:1

    Topics: Aged; Aspartic Acid; Cerebral Cortex; Choline; Corpus Striatum; Creatine; Female; Glutamic Acid; Glu

1999
Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.
    Pediatric research, 1999, Volume: 46, Issue:4

    Topics: Adolescent; Age Factors; Aspartic Acid; Basal Ganglia; Brain; Brain Neoplasms; Cerebellum; Child; Ch

1999
Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats.
    Neuroreport, 2000, Jun-26, Volume: 11, Issue:9

    Topics: Animals; Behavior, Animal; Cerebral Ventricles; Cognition Disorders; Corpus Striatum; Creatine; Male

2000
Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation).
    Neurology, 2000, Nov-14, Volume: 55, Issue:9

    Topics: Brain Chemistry; Child, Preschool; Creatine; Epilepsy; Guanidinoacetate N-Methyltransferase; Humans;

2000